Pfizer says Omicron-specific booster vaccine shows promising results but not yet approved for SA

The South African Health Products Regulatory Authority is waiting for a response from pharmaceutical company Pfizer before considering an application for an Omicron-specific booster vaccine.
Source:
Source: Pixabay

Pharmaceutical company Pfizer on Thursday announced that a trial for their Omicron-specific booster vaccine, aimed at fighting infections caused by the BA.4 and BA.5 subvariants, has shown great promise.

The trial was only for adults.

Read the original article on Daily Maverick.


 
For more, visit: https://www.bizcommunity.com